Whitehawk Therapeutics, Inc. (WHWK)
NASDAQ: WHWK · Real-Time Price · USD
1.650
-0.020 (-1.20%)
May 13, 2025, 4:00 PM - Market closed
Whitehawk Therapeutics Employees
Whitehawk Therapeutics had 40 employees as of December 31, 2024. The number of employees decreased by 49 or -55.06% compared to the previous year.
Employees
40
Change (1Y)
-49
Growth (1Y)
-55.06%
Revenue / Employee
$694,375
Profits / Employee
$690,350
Market Cap
77.19M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 40 | -49 | -55.06% |
| Dec 31, 2023 | 89 | 10 | 12.66% |
| Dec 31, 2022 | 79 | 40 | 102.56% |
| Dec 31, 2021 | 39 | 31 | 387.50% |
| Dec 31, 2020 | 8 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
WHWK News
- 5 days ago - Whitehawk Reports First Quarter 2025 Financial Results and Recent Highlights - PRNewsWire
- 7 weeks ago - Whitehawk Therapeutics Completes Strategic Transformation with Successful Closing of Sale of Aadi Subsidiary to Kaken Pharmaceuticals - PRNewsWire
- 7 weeks ago - Whitehawk Therapeutics Inc. (WHWK) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Aadi Bioscience Relaunches as Whitehawk Therapeutics Marking Evolution into ADC Company - PRNewsWire